跳至主要内容
临床试验/JPRN-UMIN000016173
JPRN-UMIN000016173已完成2 期

A phase 2 trial of weekly nab-paclitaxel for advanced non-small cell lung cancer without EGFR mutation nor ALK fusion gene in salvage setting - NICE Salvage study

Kurashiki Central Hospital0 个研究点目标入组 38 人开始时间: 2015年1月15日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)symptomatic brain metastasis 2)massive or uncontrolable pleural effusion 3)less than two weeks after palliative irradiation for bone metastases or the brain metastasis except the primary tumor 4)previous chemotherapy with paclitaxel or nab-paclitaxel 5)active concomitant malignancy 6)active infectious disease 7)severe comorbidity 8)history of severe drug allergy 9)continuous steroid therapy 10)phsychiatry disease 11)pregnant or lactating woman 12)HBs antigen positive 13)Peripheral neuropathy>CTCAE Grade2 14)interstitial pneumoia or active lung fibrosis on chest X-ray 15)Otherwise determined by the investigator to be unsuitable as a subject in this study

研究者

相似试验